6264-0395 Screening compound: 7-bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl 6-aminohexanoate

6264-0395 Screening compound: 7-bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl 6-aminohexanoate
6264-0395 Screening compound: 7-bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl 6-aminohexanoate alternative view

Chemical Structure Depiction of ChemDiv screening compound 6264-0395
7-bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl 6-aminohexanoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6264-0395

Molecular Formula

C21H21BrClN3O3 (C21 H21 BrClN3 O3)

Compound Name

7-bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl 6-aminohexanoate

IUPAC name

7-bromo-5-(2-chlorophenyl)-2-oxo-23-dihydro-1H-14-benzodiazepin-3-yl 6-aminohexanoate

SMILES

NCCCCCC(OC1N=C(c(cccc2)c2Cl)c(cc(cc2)Br)c2NC1=O)=O

InChI

InChI=1S/C21H21BrClN3O3/c22-13-9-10-17-15(12-13)19(14-6-3-4-7-16(14)23)26-21(20(28)25-17)29-18(27)8-2-1-5-11-24/h3-4,6-7,9-10,12,21H,1-2,5,8,11,24H2,(H,25,28)/t21-/m1/s1

InChI Key

DQGISEAJGZPWKI-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD04008140

Chemical and Physical Properties

Saltdata

HBr

Molecular Weight

478.77

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.081

Distribution Coefficient, logD

0.508

Water Solubility, LogSw

-3.68

Polar Surface Area

74.646

Acid Dissociation Constant (pKa)

9.95

Base Dissociation Constant (pKb)

9.97

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

6264-0395 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with 6264-0395 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6264-0395?
Check Price and Availability of 6264-0395, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6264-0395 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6264-0395
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6264-0395
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6264-0395 available by request